MedTrace Logo

Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy

NCT00629096 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2014-12-05

No results posted yet for this study

Summary

The main aim of the study is to determine whether intracoronary infusion of autologous bone marrow mononuclear cells can improve the ventricular function of patients with idiopathic dilated cardiomyopathy.Secondary end-points will be:

1. To evaluate possible changes in patient functional capacity and
2. to identify the biological characteristics of the bone marrow graft that might influence on functional recovery.

Conditions

  • Dilated Cardiomyopathy

Interventions

PROCEDURE

Intracoronary infusion of autologous bone marrow cells

Autologous mononuclear bone marrow cells will be administered by intracoronary infusion via a percutaneous catheter

Sponsors & Collaborators

  • Iniciativa Andaluza en Terapias Avanzadas

    collaborator OTHER

  • Fundación Pública Andaluza Progreso y Salud

    lead OTHER

Principal Investigators

  • Jose Suarez de Lezo, MD, PhD · Department of Cardiology. Reina Sofía University Hospital

  • I. Concepción Herrera, MD, PhD · Department of Hematology.Reina Sofia University Hospital

  • Manuel Pan, MD, PhD · Department of Cardiology. Reina sofia University Hospital

  • Jose Maria Arizon, MD · Department of Cardiology. Reina Sofía university Hospital

  • Miguel Angel Romero, MD, PhD · Department of Cardiology. Reina Sofía University Hospital

  • Ramon Ribes, MD, PhD · Department of Radiology. Reina Sofía University Hospital

  • Joaquin Sanchez, MD, PhD · Department of Hematology. Reina Sofía Unuversity Hospital

  • Antonio Torrers, MD, PhD · Department of Hematology. Reina Sofía University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-08-31
Completion
2010-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00629096 on ClinicalTrials.gov